RE:Prior to the vote on the Vivo acquisition, managementNo worries piduks, thats what makes these investor sites so valuable - espectful difference of opinion
I dont think management are the only ones who believe Labs shareprice is undervalued as most of the anaysts also have it pegged between .10 to .18 cents.
Managements comments regarding same can be coming from several angles that we may not know about. Are they aware a firm is intentionally holding it back perhaps.
As far as a NCIB at this time goes, thats a slippery slope as it does not increase the shareprice, it just gives the shareholders a larger percentage of ownership, but it does reduce cash on hand, and they are not flush with cash or outstanding receiveables.
These guys have stated they are still looking for potential acquistions, so cash is king at the moment. That said I hope they dont get ahead of themselves by buying up undervalued projects..
The industry is full of those barely treading water clinging on to life, so I hope management stays the course striving for revenue translating to profits.
Look no further than Heritage Cannabis (CANN) who not that long ago were promoting their CBD foothold in Brazil
https://mjbizdaily.com/canadian-producer-heritage-cannabis-granted-creditor-protection/